1. Home
  2. JAZZ vs VERX Comparison

JAZZ vs VERX Comparison

Compare JAZZ & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAZZ
  • VERX
  • Stock Information
  • Founded
  • JAZZ 2003
  • VERX 1978
  • Country
  • JAZZ Ireland
  • VERX United States
  • Employees
  • JAZZ N/A
  • VERX N/A
  • Industry
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • VERX Computer Software: Prepackaged Software
  • Sector
  • JAZZ Health Care
  • VERX Technology
  • Exchange
  • JAZZ Nasdaq
  • VERX Nasdaq
  • Market Cap
  • JAZZ 7.3B
  • VERX 8.7B
  • IPO Year
  • JAZZ 2007
  • VERX 2020
  • Fundamental
  • Price
  • JAZZ $121.18
  • VERX $56.40
  • Analyst Decision
  • JAZZ Buy
  • VERX Buy
  • Analyst Count
  • JAZZ 14
  • VERX 13
  • Target Price
  • JAZZ $173.93
  • VERX $54.25
  • AVG Volume (30 Days)
  • JAZZ 567.6K
  • VERX 927.8K
  • Earning Date
  • JAZZ 02-26-2025
  • VERX 02-27-2025
  • Dividend Yield
  • JAZZ N/A
  • VERX N/A
  • EPS Growth
  • JAZZ 458.10
  • VERX N/A
  • EPS
  • JAZZ 7.04
  • VERX 0.19
  • Revenue
  • JAZZ $3,992,712,000.00
  • VERX $643,234,000.00
  • Revenue This Year
  • JAZZ $7.51
  • VERX $18.54
  • Revenue Next Year
  • JAZZ $6.84
  • VERX $14.66
  • P/E Ratio
  • JAZZ $17.22
  • VERX $295.59
  • Revenue Growth
  • JAZZ 5.23
  • VERX 17.25
  • 52 Week Low
  • JAZZ $99.06
  • VERX $24.17
  • 52 Week High
  • JAZZ $134.17
  • VERX $57.74
  • Technical
  • Relative Strength Index (RSI)
  • JAZZ 46.66
  • VERX 66.44
  • Support Level
  • JAZZ $118.72
  • VERX $50.66
  • Resistance Level
  • JAZZ $124.66
  • VERX $53.13
  • Average True Range (ATR)
  • JAZZ 2.82
  • VERX 1.75
  • MACD
  • JAZZ -0.21
  • VERX 0.29
  • Stochastic Oscillator
  • JAZZ 31.62
  • VERX 95.62

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.

Share on Social Networks: